Johnson & Johnson vs. Sagimet Biosciences Inc. Series A Common Stock
JNJ
Johnson & Johnson
$276.46 +0.46%
VS SGMTSagimet Biosciences Inc. Series A Common Stock
$9.92 -4.89%
Johnson & Johnson and Sagimet Biosciences Inc. Series A Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | SGMT | |
|---|---|---|
| Market Cap | $662.49 billion | $739.58 million |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | SGMT | |
|---|---|---|
| Dividend Yield | 1.94% | — |
JNJ and SGMT split the dividend factors evenly.
Risk & Sentiment
| JNJ | SGMT | |
|---|---|---|
| Short Interest | 0.67% | 0.46% |
SGMT leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, SGMT overview, SGMT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.